Literature DB >> 12842780

The work environment and workers' health in four large office buildings.

H Jasmine Chao1, Joel Schwartz, Donald K Milton, Harriet A Burge.   

Abstract

We conducted a 1-year epidemiologic study in Boston, Massachusetts, beginning May 1997, to examine the associations between environmental factors and office workers' health. We recruited 98 subjects (81 females and 17 males) in 21 offices in four office buildings. We conducted environmental sampling every 6 weeks and concurrently administered detailed questionnaires to collect information on work-related symptoms, psychosocial factors, and perceptions of the office environments. In multivariate analyses, eye irritation was positively correlated with floor dust [odds ratio (OR) = 1.46; 95% confidence intervals (CI), 1.14-1.86] and reported lack of office cleanliness (OR = 1.52; 95% CI, 1.11-2.08). Nonspecific symptoms were positively associated with unidentified chair fungi (OR = 1.87; 95% CI, 1.11-3.15) and several self-reported conditions, including a history of asthma (OR = 3.15; 95% CI, 1.26-7.87), more people in offices (OR = 1.71; 95% CI, 1.16-2.51), lack of office cleanliness (OR = 2.85; 95% CI, 1.72-4.73), and low job satisfaction (OR = 1.72; 95% CI, 1.06-2.81). Upper respiratory symptoms were positively associated with total fungal concentrations recovered from chair dust (OR = 1.35; 95% CI, 1.07-1.70) and the following self-reported conditions: more people in offices (OR = 1.45; 95% CI, 1.01-2.08), lack of office cleanliness (OR = 1.62; 95% CI, 1.15-2.30), and jobs frequently requiring hard work (OR = 1.43; 95% CI, 1.05-1.95). This study emphasizes the importance of maintaining a clean, uncrowded workspace and the importance of chair fungi as a correlate for health effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842780      PMCID: PMC1241581          DOI: 10.1289/ehp.5697

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  20 in total

1.  Testing the association between residential fungus and health using ergosterol measures and cough recordings.

Authors:  R E Dales; D Miller; J White
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  Subjective perceptions, symptom intensity and performance: a comparison of two independent studies, both changing similarly the pollution load in an office.

Authors:  P Wargocki; L Lagercrantz; T Witterseh; J Sundell; D P Wyon; P O Fanger
Journal:  Indoor Air       Date:  2002-06       Impact factor: 5.770

3.  Influence of indoor climate on the sick building syndrome in an office environment. The Danish Indoor Climate Study Group.

Authors:  P Skov; O Valbjørn; B V Pedersen
Journal:  Scand J Work Environ Health       Date:  1990-10       Impact factor: 5.024

4.  Symptoms and microenvironmental measures in nonproblem buildings.

Authors:  M J Hodgson; J Frohliger; E Permar; C Tidwell; N D Traven; S A Olenchock; M Karpf
Journal:  J Occup Med       Date:  1991-04

5.  An investigation of the relationship between microbial and particulate indoor air pollution and the sick building syndrome.

Authors:  J Harrison; C A Pickering; E B Faragher; P K Austwick; S A Little; L Lawton
Journal:  Respir Med       Date:  1992-05       Impact factor: 3.415

6.  Consistent pattern of elevated symptoms in air-conditioned office buildings: a reanalysis of epidemiologic studies.

Authors:  M J Mendell; A H Smith
Journal:  Am J Public Health       Date:  1990-10       Impact factor: 9.308

Review 7.  Cost avoidance and productivity in owning and operating buildings.

Authors:  J E Woods
Journal:  Occup Med       Date:  1989 Oct-Dec

8.  Sick building syndrome: a study of 4373 office workers.

Authors:  S Burge; A Hedge; S Wilson; J H Bass; A Robertson
Journal:  Ann Occup Hyg       Date:  1987

9.  Volatile organic compounds, respirable dust, and personal factors related to prevalence and incidence of sick building syndrome in primary schools.

Authors:  D Norbäck; M Torgén; C Edling
Journal:  Br J Ind Med       Date:  1990-11

10.  Dustborne fungi in large office buildings.

Authors:  Hsing Jasmine Chao; Donald K Milton; Joel Schwartz; Harriet A Burge
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

View more
  7 in total

1.  Air- and dustborne mycoflora in houses free of water damage and fungal growth.

Authors:  W Elliott Horner; Anthony G Worthan; Philip R Morey
Journal:  Appl Environ Microbiol       Date:  2004-11       Impact factor: 4.792

2.  No consistent risk factor pattern for symptoms related to the sick building syndrome: a prospective population based study.

Authors:  Charlotte Brauer; Henrik Kolstad; Palle Ørbaek; Sigurd Mikkelsen
Journal:  Int Arch Occup Environ Health       Date:  2006-01-11       Impact factor: 3.015

3.  Fungal pollution of indoor environments and its management.

Authors:  A A Haleem Khan; S Mohan Karuppayil
Journal:  Saudi J Biol Sci       Date:  2012-06-15       Impact factor: 4.219

4.  Evaluating prevalence and risk factors of building-related symptoms among office workers: Seasonal characteristics of symptoms and psychosocial and physical environmental factors.

Authors:  Kenichi Azuma; Koichi Ikeda; Naoki Kagi; U Yanagi; Haruki Osawa
Journal:  Environ Health Prev Med       Date:  2017-04-12       Impact factor: 3.674

Review 5.  Airborne environmental injuries and human health.

Authors:  Andrea T Borchers; Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2006-08       Impact factor: 8.667

6.  Elements of yogic practice: Perceptions of students in healthcare programs.

Authors:  Christiane Brems; Dharmakaya Colgan; Heather Freeman; Jillian Freitas; Lauren Justice; Margaret Shean; Kari Sulenes
Journal:  Int J Yoga       Date:  2016 Jul-Dec

7.  Effects of neighborhood building density, height, greenspace, and cleanliness on indoor environment and health of building occupants.

Authors:  Isabelle Y S Chan; Anita M M Liu
Journal:  Build Environ       Date:  2018-06-14       Impact factor: 6.456

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.